PRGO: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/0d687ccd-baf4-468f-ab4d-8fc1b7fc577d/","filing_uuid":"0d687ccd-baf4-468f-ab4d-8fc1b7fc577d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0d687ccd-baf4-468f-ab4d-8fc1b7fc577d/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul Ray","dt_posted":"2026-07-20T15:56:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 10th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":72538,"url":"https://lda.gov/api/v1/clients/72538/","client_id":72538,"name":"PERRIGO COMPANY PLC","general_description":"Self-care products","client_government_entity":null,"client_self_select":false,"state":null,"state_display":null,"country":"IE","country_display":"Ireland","ppb_state":null,"ppb_state_display":null,"ppb_country":"IE","ppb_country_display":"Ireland","effective_date":"2026-03-18"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal policy matters related to the manufacturing of infant formula and other public health issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151680,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"RAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"Federal policy matters related to the manufacturing of infant formula and other public health issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151680,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"RAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}